(Total Views: 380)
Posted On: 12/21/2023 9:07:59 PM
Post# of 36541
Generex (GNBT) is done. NuGenerex (NUGX/NGIO) is another story.
However, Olaregen Therapeutix and Graysen Biotechnology seem to be seperate...
Youfeng (Beijing) Biotechnology Co., Ltd.
Youfeng (Beijing) Biotechnology Co., Ltd. (abbreviation: Youfeng Biology) was established in 2020 and is headquartered in Beijing. The company is deeply involved in the field of biomedicine with an "industry-university-research" integrated development model. Based on the world's leading new peptide technology platform and medical device research and development foundation, the company coordinates resources such as domestic and foreign research talents, basic science, clinical medicine, bioinformatics, and international cooperation, and applies the research and development results of innovative drugs and devices to the prevention, treatment and rehabilitation of infectious diseases, tumors, and chronic diseases.
The company has 8 subsidiaries, including 5 in China, namely: Youfeng (Shanghai) Biotechnology Co., Ltd., Youfeng (Zhejiang) Biotechnology Co., Ltd., Youfeng (Hong Kong) Biotechnology Co., Ltd., Banju Biotechnology Co., Ltd. and Zhejiang Lizhen Biotechnology Co., Ltd.; 3 in the United States, namely: NuGenerex Immuno-Oncology, Inc., Olaregen Therapeutix, Inc., and Graysen Biotechnology Inc.
https://youfengbio.com/gsjj
However, Olaregen Therapeutix and Graysen Biotechnology seem to be seperate...
Youfeng (Beijing) Biotechnology Co., Ltd.
Youfeng (Beijing) Biotechnology Co., Ltd. (abbreviation: Youfeng Biology) was established in 2020 and is headquartered in Beijing. The company is deeply involved in the field of biomedicine with an "industry-university-research" integrated development model. Based on the world's leading new peptide technology platform and medical device research and development foundation, the company coordinates resources such as domestic and foreign research talents, basic science, clinical medicine, bioinformatics, and international cooperation, and applies the research and development results of innovative drugs and devices to the prevention, treatment and rehabilitation of infectious diseases, tumors, and chronic diseases.
The company has 8 subsidiaries, including 5 in China, namely: Youfeng (Shanghai) Biotechnology Co., Ltd., Youfeng (Zhejiang) Biotechnology Co., Ltd., Youfeng (Hong Kong) Biotechnology Co., Ltd., Banju Biotechnology Co., Ltd. and Zhejiang Lizhen Biotechnology Co., Ltd.; 3 in the United States, namely: NuGenerex Immuno-Oncology, Inc., Olaregen Therapeutix, Inc., and Graysen Biotechnology Inc.
https://youfengbio.com/gsjj
(0)
(0)Scroll down for more posts ▼
